How to investigate the temporalities of health

Forum Qualitative Sozialforschung

Volumn 8, Issue 1, 2007, Pages

  Moreira, Tiago ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Health; Hypertension; Mild cognitive impairment; Risk; Temporalities

Indexed keywords

EID: 33846799113     PISSN: None     EISSN: 14385627     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Abel-Smith, Brian (1996). The escalation of health care costs: How did we get there? In OECD (Ed.), Health care reform - the will to change (1st ed., Vol. 8, pp.17-30). Paris: OECD.
2. Armstrong, David (1985). Space and time in British general practice. Social Science and Medicine, 20(7), 659-666.
3. Armstrong, David (1995). The rise of surveillance medicine. Sociology of Health and Illness, 17(3), 393-404.
4. Artero, Sylvaine; Tierney, Mary C.; Touchon, Jacques & Ritchie, Karen (2003). Prediction of transition from cognitive impairment to senile dementia: A prospective, longitudinal study. Acta Psychiatrica Scandinavica, 107(5), 390-393.
5. Ashmore, Malcom; Mulkay, Michael & Pinch, Trevor (1989). Health and efficiency: A sociology of health economics. Milton Keynes: Open University Press.
6. Beck, Ulrich; Giddens, Anthony & Lash, Scott (1994). Reflexive modernization. Stanford: Stanford University Press.
7. Callon, Michel (1998). An essay on framing and overflowing: Economic externalities revisited by sociology. In Michel Callon (Ed.), The laws of the markets (pp.244-269). Oxford: Blackwell.
8. Callon, Michel & Law, John (2005). On qualculation, agency and otherness. Environment and Planning D: Society and Space, 23(5) 717-733
9. Callon, Michel; Lascoumes, Pierre & Barthe, Yannic (2001). Agir dans un monde uncertain: Essai sur la democratie technique. Paris: Seuil.
10. Clarke, Adele E.; Mamo, Laura; Fishman, Jennifer R.; Shim, Janet K. & Fosket, Jennifer Ruth (2003). Biomedicalization: Technoscientific transformations of health, illness, and U.S. Biomedicine. American Sociological Review, 68(April), 161-194.
11. Cochoy, Frank (2002). Une sociologie du packaging ou l'âne de buridan face au marché. Paris: PUF. Conrad, Peter (1992). Medicalization and social control. Annual Review of Sociology, 18(1), 209-232.
12. Conrad, Peter (1994). Wellness as virtue: Morality and the pursuit of health. Culture, Medicine and Psychiatry, 18(3), 385-401.
13. Flynn, Rob (2002). Clinical governance and govemmentality. Health Risk & Society, 4(2), 155-173.
14. Folstein, Marshall F.; Folstein, Susan E. & McHugh, Paul R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
15. Food and Drug Adminstration. (2001). Peripheral and Central Nervous System Drugs Advisory Committee (transcript: volume I). Washington: Department of Health and Human Services.
16. Foucault, Michel (1986). Afterword: The subject and power. In Hubert L. Dreyfus & Paul Rabinow (Eds.), Michel Foucault: Beyond structuralism and hermeneutics (pp.208-226): Brighton: Harvester Press.
17. Gauthier, Serge; Reisberg, Barry; Zaudig, Michael; Petersen, Ronald C.; Ritchie, Karen; Broich, Karl; Belleville, Sylvie; Brodaty, Henry; Bennett, David; Chertkow, Howard; Cummings, Jeffrey; de Leon, Mony; Feldman, Howard; Ganguli, Mary; Hampel, Harald; Scheltens, Philip; Tierney, Mary C.; Whitehouse, Peter & Winblad, Bengtand on behalf of the participants of the International Psychogeriatric Association Expert Conference on mild cognitive impairmen (2006). Mild cognitive impairment. The Lancet, 367, 1262-1270.
18. Greco, Monica (1993). Psychosomatic subjects and the "duty to be well": Personal agency within medical rationality. Economy and Society, 22(3), 357-372.
19. Green, Peter (2004). Life in the real world. BMJ, 329, 569.
20. Hallowell, Nina & Lawton, Julia (2002). Negotiating present and future selves: Managing the risk of hereditary ovarian cancer by prophylactic surgery. Health, 6(4), 423-443.
21. Hunter, Katherine M. (1991). Doctors' stories: The narrative structure of medical knowledge. Princeton, NJ: Princeton University Press.
22. Iliffe, Steve; Manthorpe, Jill & Eden, Alison (2003). Sooner or later? Issues in the early diagnosis of dementia in general practice: A qualitative study. Family Practice, 20(4), 376-381.
23. Latour, Bruno (2004). Why has critique run out of steam? From matters of fact to matters of concern. Critical Inquiry, 30, 225-248.
24. Lemke, Thomas (2001). "The birth of bio-politics": Michel Foucault's lecture at the college de france on neo-liberal govemmentality. Economy and Society, 30(2), 190-207.
25. Light, Donald (2000). The origins and rise of managed care. In Phil Brown (Ed.), Perspectives in medical sociology (pp.484-503). Prospect Heights III: Waveland Press.
26. Loveman, Emma; Green, Colin; Kirby, Jo; Takeda, Andrea; Picot, Joanna; Bradbury, Jason; Payne, Elizabeth & Clegg, Andrew (2005). The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine, and memantine for Alzheimer's disease. Southampton: Southamptoon Health Technology Assessment Centre.
27. May, Carl; Rapley, Tim, Moreira, Tiago; Finch, Tracy & Heaven, Ben (2006). Technogovernance: Evidence, subjectivity, and the clinical encounter in primary care medicine. Social Science and Medicine, 62(4), 1022-1030.
28. Miller, Peter (2001). Governing by numbers: Why calculative practices matter. Social Research, 68(2), 379-396.
29. Moreira, Tiago (2005). Diversity in clinical guidelines: The role of repertoires of evaluation. Social Science and Medicine, 60, 1975-1985.
30. Moreira, Tiago (2006a/in press). Testing promises: Truth and hope in drug development and evaluation in Alzheimer's disease. In Jesse F. Ballenger, Peter J. Whitehouse, Constantine Lyketsos, Peter Rabins & Jason H. T. Karlawish (Eds.), Do we have a pill for that? Interdisciplinary perspectives on the development, use and evaluation of drugs in the treatment of dementia (.Baltimore: Johns Hopkins University Press.
31. Moreira, Tiago (2006b). Heterogeneity and coordination of blood pressure in neurosurgery. Social Studies of Science, 36(1), 69-97.
32. National Guideline Research and Development Unit (2004). Essential hypertension: Managing adult patients in primary care. Newcastle upon Tyne: Centre for Health Services Research, University of Newcastle upon Tyne.
33. National Institute for Clinical Excellence (2005). Appraisal consultation document: Donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease, London. Available at http://www.nice.org.uk/page.aspx?o=245912 [Accessed 1/4/05].
34. National Institute for Clinical Excellence (2006). Appraisal consultation document: Donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease, London. Available at http://www.nice.org.uk/page.aspx?o=245912 [Accessed 23/1/06].
35. Novas, Carlos & Rose, Nikolas (2000). Genetic risk and the birth of the somatic individual. Economy and Society, 29(4), 485-513.
36. Petersen, Alan & Lupton, Deborah (1997). The new public health: Health and self in the age of risk. London: Sage.
37. Petersen, Ronald C.; Smith, Glenn E.; Waring, Stephen C.; Ivnik, Robert J.; Tangalos, Eric G. & Kokmen, Emre (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56(3), 303-308.
38. Petersen, Ronald C.; Doody, Rachelle; Kurz, Alexander; Mohs, Richard C.; Morris, John C.; Rabins, Peter V.; Ritchie, Karen; Rossor, Martin; Thal, Leon & Winblad, Bengt(2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58(12), 1985-1992.
39. Petersen, Ronald; Thomas, Ronald G; Grundman, Michael; Bennett, David; Doody, Rachelle; Ferris, Steven; Galasko, Douglas; Jin, Shelia; Kaye, Jeffrey; Levey, Allan; Pfeiffer, Eric; Sano, Mary; van Dyck, Christopher; Thal, Leon J. for the Alzheimer's Disease Cooperative Study Group (2006). Vitamin e and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352(23), 2379-2388.
40. Porter, Theodore M. (1995). Trust in numbers: The pursuit of objectivity in science and public life. Princeton, NJ: Princeton University Press.
41. Ritchie, Karen; Artero, Sylvain & Touchon, Jaques (2001). Classification criteria for mild cognitive impairment: A population-based validation study. Neurology, 56(1), 37-42.
42. Rose, Nikolas & Miller, Peter (1992). Political power beyond the state: Problematics of government. British Journal of Sociology, 42(2), 173-205.
43. Rothstein, William (2003). Public health and the risk factor: A history of an uneven medical revolution. Rochester: University of Rochester Press.
44. Schneider, Lon S. (2004). Ad2000: Donepezil in Alzheimer's disease. The Lancet, 363, 2100-2101.
45. Swales, John D. (1985). Platt versus pickering: An episode in recent medical history. Cambridge: The Keynes Press.
46. Timmerman, Carsten (2005). A matter of degree (unpublished paper). Manchester: Center for the History of Science, Technology and Medicine, University of Manchester.
47. Titscher, Susanne; Meyer, Michael; Vetter, Eva & Wodak, Ruth (2000). Methods of text and discourse analysis: in search of meaning. London: Sage
48. Wimo, Anders & Winblad, Berg (2003). Pharmacoeconomics of mild cognitive impairment. Acta Neurologica Scandinavica, 107(Suppl. 179), 94-99.
49. Wood, Fiona; Prior, Lindsay & Gray, Jonathon (2003). Translations of risk: Decision making in a cancer genetics service. Health Risk & Society, 5(2), 185-198.